Insider Transactions in Q2 2023 at Allovir, Inc. (ALVR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2023
|
Gilead Sciences Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,930,870
+14.98%
|
$8,792,610
$3.75 P/Share
|
|
Jun 09
2023
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,045
-3.75%
|
$25,225
$5.64 P/Share
|
|
May 18
2023
|
Diana Brainard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,536
-0.49%
|
$18,144
$4.21 P/Share
|
|
May 11
2023
|
Shawn Tomasello |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+50.0%
|
-
|
|
May 11
2023
|
Morana Jovan Embiricos |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+34.93%
|
-
|
|
May 11
2023
|
David Hallal |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+1.63%
|
-
|
|
May 11
2023
|
Malcolm Brenner |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+34.93%
|
-
|
|
May 11
2023
|
Jeffrey S Bornstein |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+31.76%
|
-
|
|
May 11
2023
|
Juan Vera |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+1.45%
|
-
|
|
May 11
2023
|
Derek N. Adams |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+50.0%
|
-
|
|
Apr 20
2023
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
349
-0.26%
|
$1,047
$3.63 P/Share
|
|
Apr 20
2023
|
Vikas Sinha |
SELL
Open market or private sale
|
Direct |
1,466
-0.12%
|
$4,398
$3.63 P/Share
|
|
Apr 19
2023
|
Diana Brainard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,408
-0.9%
|
$25,224
$3.71 P/Share
|
|
Apr 19
2023
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
348
-0.26%
|
$1,044
$3.71 P/Share
|
|
Apr 19
2023
|
Vikas Sinha |
SELL
Open market or private sale
|
Direct |
1,217
-0.1%
|
$3,651
$3.71 P/Share
|